![Raul Rodriguez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raul Rodriguez
Algemeen Directeur bij
RIGEL PHARMACEUTICALS, INC.
Vermogen: 9 M $ op 31-05-2026
Profiel
Raul R.
Rodriguez is currently President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. since 2014, with employment at the company starting in 2000.
Formerly, Mr. Rodriguez was Executive Director-Business Development at Scios, Inc. from 1994 to 1997 and Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Education includes graduate studies at the University of Illinois, an MBA from Stanford Graduate School of Business, and undergraduate studies at Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-06-2026 | 279.593 ( 1,51% ) | 9 M $ | 31-05-2026 |
Actieve functies van Raul Rodriguez
| Bedrijven | Functie | Begin |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Algemeen Directeur | 21-11-2014 |
Eerdere bekende functies van Raul Rodriguez
| Bedrijven | Functie | Einde |
|---|---|---|
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Operationeel Directeur | 01-03-2000 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Corporate Officer/Principal | 01-03-1997 |
Opleiding van Raul Rodriguez
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
